GSE115395 enzalutamide LNCaP 2 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE115395_enzalutamide_LNCaP_2_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE115395_enzalutamide_LNCaP_2_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE115395_enzalutamide_LNCaP_2_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE115395_enzalutamide_LNCaP_2_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

multidrug resistance-related protein

Gene

DPPA2 upstream binding RNA

Gene

DUS4L-BCAP29 readthrough

Gene

NF-kappaB interacting lncRNA

Gene

sorbitol dehydrogenase 2, pseudogene

Gene

uncharacterized LOC124901321

Gene

long intergenic non-protein coding RNA 3124

Gene

SLC5A4 antisense RNA 1

Gene

HECW2 antisense RNA 1

Gene

SAP30 divergent transcript

  • Gene

    multidrug resistance-related protein


  • Gene

    DPPA2 upstream binding RNA


  • Gene

    DUS4L-BCAP29 readthrough


  • Gene

    NF-kappaB interacting lncRNA


  • Gene

    sorbitol dehydrogenase 2, pseudogene


  • Gene

    uncharacterized LOC124901321


  • Gene

    long intergenic non-protein coding RNA 3124


  • Gene

    SLC5A4 antisense RNA 1


  • Gene

    HECW2 antisense RNA 1


  • Gene

    SAP30 divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.